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A B S T R A C T
Cisplatin, as an eﬀective chemotherapeutic agent, is widely used to treat verious types of cancers. Nephrotoxicity
induced by cisplatin seriously limits its clinical application. Icariin, a major and remarkable ﬂavonoid isolated
from Epimedium koreanum, has been reported to exert anti-oxidative stress and anti-inﬂammation actions. The
purpose of this study is to explore the protective eﬀect and possible mechanism of icariin on cisplatin-induced
nephrotoxicity on HEK-293 cells. In this study, icariin pretreatment for 24 h signiﬁcantly ameliorated cisplatin-
induced oxidative stress by reducing levels of malondialdehyde (MDA) and reactive oxygen species (ROS), while
increasing level of glutathione (GSH) in HEK-293 cells. Furthermore, icariin pretreatment reduced NF-κB
phosphorylation and nuclear translocation in HEK-293 cells followed by decreased secretion of IL-1β, TNF-α,
and iNOS, suggesting a suppression of inﬂammatory response. Moreover, icariin pretreatment signiﬁcantly re-
duced cellular apoptosis via reduced levels of Bax, cleaved caspase-3/9, and increased anti-apoptotic protein Bcl-
2 in the cells. Importantly, LY294002, a speciﬁc PI3K inhibitor, abrogated the anti-apoptosis eﬀect of icariin,
implicating the involvement of PI3K/Akt pathway. In summary, icariin prevents cisplatin-induced HEK-293 cell
injury by inhibiting oxidative stress, inﬂammatory response, and cellular apoptosis partly via regulating NF-κB
and PI3K/Akt signaling pathways. Icariin may serve as a potential therapeutic target against cisplatin-induced
nephrotoxicity.
1. Introduction
Cisplatin is one of the widely used antineoplastic drugs with a wide
spectrum in clinical use [1] and represents one of the common anti-
tumors drugs to treat diverse malignancies, such as ovarian cancer,
bladder tumor, and esophageal carcinoma [2]. Therapeutic eﬀects of
cisplatin are dose dependent. Nevertheless, the signiﬁcant adverse re-
actions of cisplatin are associated with high dose cisplatin therapy in-
cluding renal damage, gastrointestinal dysfunction, auditory toxicity,
peripheral nerve toxicity and kidney dysfunction [3]. Previous studies
have shown that accumulation of cisplatin in tubular cells was 5 times
more than that in other tissues, suggesting a major and severe ne-
phrotoxicity [4]. Existing data revealed that oxidative stress,
inﬂammation and apoptosis have been considered as potential me-
chanisms underlying nephrotoxicity caused by cisplatin-regimen [5].
Cisplatin-induced oxidative stress is an unbalanced redox reaction in
kidney cells, resulting in the production of reactive oxygen species
(ROS) [6]. However, overproduction of ROS may lead to lipid perox-
idation and delayed renal damage [7]. In addition, numerous studies
have shown that activated NF-κB may activate many pro-inﬂammatory
cytokines such as TNF-α and IL-1β, and induce inﬂammatory mediators
such as iNOS and COX-2 [8,9]. Furthermore, cisplatin can elevate the
level of ROS, which leads to cell injury and mitochondrial dysfunction
[10,11]. When cisplatin induces generation of ROS, pro-apoptotic
proteins are activated to induce Bax translocation to mitochondrial
outer membrane, releasing the cytochrome c into the cytosol [12].
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Upon receiving apoptosis signal from Bax, caspases 9 is initiated and
activates downstream caspase-3 to cause apoptosis [13]. More im-
portantly, excessive ROS would damage cellular macromolecules, for
example proteins, lipids and DNA, through regulation of signaling
pathways such as PI3K/Akt pathway and NF-κB pathway [5,14]. It has
been reported that LY294002, an inhibitor of the PI3K/Akt pathway,
obviously increased the cytotoxicity of cisplatin in HK-2 cells by en-
hancing its induction of apoptosis [14].
Epimedium koreanum, is a well-known traditional Chinese herbal
medicine. Icariin (Fig. 1), a major ﬂavonoid responsible for the phar-
macological actions of Epimedii Herba, was found to be increased sig-
niﬁcantly after the heating process [15]. Icariin has been shown to have
a wide range of pharmacological and biological activities, including
anti-neuronal injury [16], promotion of synaptic growth and osteo-
genesis [17], anti-inﬂammation, anti-tumor [18], and anti-depression
eﬀects [19]. In addition, a report by Deng et al. indicated that icariin
had a protective eﬀect on IL-1β-induced human nucleus pulposus cells,
and the PI3K/Akt pathway was involved in this eﬀect [20].
Here we have tested the protective eﬀect of icariin on cisplatin-in-
duced nephrotoxicity in HEK-293 cells by inhibition of oxidative stress
via reducing production of ROS and anti-oxidative enzymes, suppres-
sion of inﬂammatory response via deactivation of NF-κB phosphoryla-
tion, and alleviation of cell apoptosis via restoring PI3K/Akt signaling
pathway.
2. Materials and methods
2.1. Sample and reagents
Epimedii Herba (2.0 kg) was purchased from a regular herbal
company and identiﬁed as Epimedium koreanum by Professor Wei Li
from the College of Chinese Medicinal Materials of Jilin Agricultural
University. Acetonitrile (chromatographic purity) was purchased from
TEDIA Corporation. The reference standard including epimedin A,
epimedin B, epimedin C, ans icariin (the purities of them>98.0%) was
provided by Shanghai Yuanye Biotechnology Co, Ltd. (Shanghai,
China). Cisplatin and Dimethyl sulfoxide (DMSO) were purchased from
Sigma Chemicals (St. Louis, MO, USA). Dulbecco’s modiﬁed Eagle’s
medium (DMEM), antibiotic (10000U/mL penicillin and 10,000 μg/mL
streptomycin) and fetal bovine serum (FBS) were purchased from
Hyclone (Logan, UT, USA). 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyltetrazolium bromide (MTT) was purchased from Biotopped
Technology Co., Ltd. (Beijing, China). MDA and GSH assay kits were
purchased from Nanjing Jiancheng Institute of Biotechnology (Nanjing,
China). TNF-α and IL-1β ELISA kits were purchased from the R&D
company (Minneapolis, MN, USA). BCA protein assay kit and Hoechst
33258 dye kit were bought from Beyotime Biotechnology Co., Ltd.
(Shanghai, China). The rabbit monoclonal anti-mouse PI3K, p-PI3K,
Akt, p-Akt, NF-κB p65, p-NF-κB p65, Bax, Bcl-2, caspase-3/9, cleaved-
caspase-3/9 and GAPDH antibodies were purchased from Cell Signaling
Technology (Danvers, MA, USA). iNOS, TNF-α and IL-1β antibodies
were obtained from Wanlei Biotechnology Co., Ltd. (Shenyang China).
LY294002 was purchased from MedChemExpress Biotech (New jersey,
USA). The remaining reagents were analytical pure, and provided by
Beijing Chemical Works (Beijing, China).
2.2. Sample preparation and HPLC analysis
According to the proportion prescribed by the Chinese
Pharmacopoeia (material ratio 5:1), Epimedium koreanum were mixed
with suet oil under temperature 90℃ for 10min and fried the
Epimedium koreanum to green. Processed and unprocessed sample of
Epimedium koreanum weighted 50 g were extracted with 500mL of 70%
ethanol for three times by ultrasonic-assisted technique. The ﬁltrates
were combined and evaporated under reduced pressure, followed by
freeze-drying to obtain powders. Total ﬂavonoids in Epimedium were
analyzed using HPLC analysis on a Waters e2695 system with UV de-
tector. HPLC analyses were performed through a Hypersil ODS2 column
(250× 4.6mm, 5 μm) possessed with the chromatographic condition as
follows: column temperature of 30 °C, ﬂow rate of 1.0 mL/min, detec-
tion at 270 nm, and the mobile phase of acetonitrile (A) and water (B).
A programmed gradient eluting was used as follows: 0∼10min, 20% A;
10∼35min, 35% A; 35∼55min, 55% A; 55∼65min, 20% A. The
chromatographic peaks of four ﬂavonoids were conﬁrmed by their re-
tention times compared to the reference standards containing icariin,
epimedin A, epimedin B, and epimedin C. Quantiﬁcation was per-
formed by the integration of the peaks using the external standard
method. The content of individual ﬂavonoid was expressed as mg/g.
The determination of each sample was repeated 6 times. The icariin was
prepared using the processed Epimedium under water and acetonitrile
(v/v, 73:27). Fig. 2 shows chromatograms of Epimedium.
2.3. HEK-293 cells culture
HEK-293 cells were obtained from the ATCC Cell Bank. The HEK-
293 cells were maintained in DMEM medium supplemented with 10%
FBS, 100 μg of streptomycin/mL and 100 U of penicillin/mL in humi-
diﬁed atmosphere of 5% CO2 at 37℃. For passage, the medium was
changed every 48 h until the cells became 80∼90% conﬂuent.
2.4. Cells viability assay (MTT assay)
Cell viability was assessed by a quantitative colorimetric assay with
MTT. Cells were seeded into 96-well plates and cultured at 37℃ for
24 h, cells were pretreated with various concentrations of icariin for
24 h, and then exposure to cisplatin (20 μM) or not for 24 h. After
treatment, 20 μL MTT solution (5mg/mL) was added to the wells and
incubated at 37 °C for 3.5 h. Then, 150 μL DMSO was added to each
well, and the plates were agitated for 5min. Finally, the absorbance
was measured at 490 nm using a microplate reader (Nano, Germany).
The intensity of the color produced was proportional to the number of
living HEK-293 cells.
2.5. Oxidative stress biochemical assays
The HEK-293 cells were suspended in 12mL of fresh medium and
seeded at 100 000 cells per well in six-well culture plates, then in-
cubated for 24 h. The study design was to pretreat HEK-293 cells with
icariin for 24 h, then treat with or without cisplatin for 24 h. After
treatments, cells were scraped, pelleted and re-suspended in 1.0mL of
100mM phosphate buﬀer(pH 7.4). Cell membranes were disrupted and
the cell lysates centrifuged at 4℃, 10,000 g, for 20min. The supernatant
was separated from cell debris and used for subsequent biochemical
assay measurements. All measurements were normalized to the protein
content of the cell lysates.
Fig. 1. Chemical structures of icariin.
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2.6. Inﬂammatory cytokine assays
After experimental treatments, cell membranes were disrupted and
the cell lysates centrifuged at 4℃, 10,000 g, for 20min. The supernatant
was separated from cell debris by a tissue tearor and used for sub-
sequent measurements. The contents of TNF-α and IL-1β in the super-
natant of cells were determined using ELISA assay kits according to the
manufacture’s protocols (R&D, Minneapolis, MN, USA). The absorbance
was measured at 450 nm by ELISA reader (Bio-Rad, California, USA).
2.7. ROS staining
The relative levels of intracellular ROS were determined by a
ﬂuorometric assay (DCF-DA assay, Wanlei Biotechnology, Shenyang
China) according to the manufactures’ protocols. HEK-293 cells were
seeded in 6-well microplates, treated HEK-293 cells were incubated
with 1 μMDCFH-DA at 37℃ for 12 h. Then the medium was removed
and cells were washed by PBS twice prior to imaging. Relative DCF
ﬂuorescence intensity of treated cells was expressed as a percentage of
cisplatin-induced group (Leica TCS SP8, solms, Germany).
2.8. Hoechst 33258 staining
The HEK-293 cell were stained using the Hoechst 33258 solution
with 10 μg/mL as described previous. The slides were visualized using a
Leica microscope (Leica TCS SP8, solms, Germany). Image-Pro plus 6.0
software (Media Cybernetics, Maryland, and USA) was applied to
evaluate the degree of HEK-293 cell apoptosis through quantifying the
fragmented and condensed staining.
2.9. Western blotting analysis
Western blot analysis was performed as described previously [21].
Protein samples from HEK-293 cell were separated by 12% SDS-PAGE
gel and electrophoretically transferred to PVDF membranes, and then
the membranes were blocked with 5% non-fat milk for 3.5 h and in-
cubated with primary antibodies including Bax (1:2000), Bcl-2
(1:2000), caspase-3/9 (1:1000), cleaved-caspase-3/9 (1:1000), PI3K
(1:1000), p-PI3K (1:1000), Akt (1:1000), p-Akt (1:1000), INOS (1:500),
TNF-α (1:500), IL-1β (1:500), NF-κB (p65) (1:1000), p-NF-κB (p-p65)
(1:1000) and GAPDH (1:1000) overnight at 4℃. After that, the mem-
branes were incubated with the secondary antibodies at room tem-
perature for 1 h. Signals were detected using Emitter Coupled Logic
(ECL) substrate (Pierce Chemical Co., Rockford, IL, USA). Protein band
intensities were analyzed using Quantity One software (Bio-Rad La-
boratories, Hercules, CA, USA).
2.10. Statistical analysis
All data were expressed as the mean ± standard deviation (SD).
The data were analyzed using a two-tailed test or a one-way analysis of
variance (ANOVA). GraphPad Prism 6.04 software (GraphPad Software,
La Jolla California, USA) was used to create the resulting data charts.
The p values less than 0.05 or 0.01 were considered as statistically
signiﬁcant diﬀerences.
Fig. 2. HPLC chromatogram of standard solution (A). HPLC proﬁles of raw Epimedium koreanum (B) and heat-processed Epimedium koreanum at 90℃ for 10min (C).
(1) Epimedin A, (2) Epimedin B, (3) Epimedin C, (4) Icariin.
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3. Results
3.1. Icariin protected cisplatin-induced cell damage on HEK-293 cell
viability
To evaluate the eﬀect of cisplatin or icariin on HEK-293 cells, cell
viability was determined using MTT assay. As shown in Fig. 3A, cis-
platin exposure for 24 h reduced HEK-293 cell viability in a dose-de-
pendent manner. Compared with normal control group, the experi-
mental groups (5, 10, 20, 40, and 80 μM of cisplatin) exerts signiﬁcantly
statistical diﬀerences on cell viability (p < 0.05 or p < 0.01 or p <
0.001). According to the results, 20 μM (p < 0.01) was chosen for the
subsequent experiments. In Fig. 3B, the result shows that icariin did not
aﬀect cell viability in the dose range from 0.25 to 2.0 μM, indicating no
toxicity on HEK-293 cells at this dose range. As shown in Fig. 3C,
compared with normal control group, icariin with concentration range
from 0.25 to 2.0 μM exerted obvious protective eﬀect on cell viability in
a dose-dependent manner (p<0.05 or p < 0.01).
3.2. Icariin attenuated oxidative stress of HEK-293 cells induced by
cisplatin treatment
The eﬀects of icariin on cisplatin-induced oxidative stress were
shown in Fig. 4A and B. In the present study, we examined the levels of
GSH and MDA in HEK-293 cells. GSH is one of the most important
endogenous antioxidants protecting cells against oxidative stress da-
mage. Cisplatin induced a signiﬁcant reduction in GSH level compared
to the normal group (p<0.01). Meanwhile, as a lipid peroxidation
marker, the MDA levels were markedly increased after cisplatin ex-
posure (p<0.01). More interestingly, compared to the cisplatin group,
icariin at indicated dose range inhibited the overproduction of MDA
and increased the GSH level, respectively (p<0.05 or p<0.01).
The degree of oxidative stress after cisplatin exposure was also de-
termined by intracellular ROS. The accumulation of intracellular ROS
was detected by ﬂuorescein-labeled dye, DCFH-DA. HEK-293 cells were
treated with diﬀerent concentrations of icariin in the presence of cis-
platin and measured for ﬂuorescent intensity. Cells treated with cis-
platin resulted in a signiﬁcant increase in intracellular ROS generation.
However, pretreatment with icariin for 24 h reduced the intracellular
ROS levels caused by cisplatin exposure. Icariin pretreatments at 0.25,
0.5, and 1.0 μM signiﬁcantly reduced the production of ROS by 34.11%,
72.14%, and 84.63%, respectively (Fig. 4C and D) (p<0.05 or
p<0.01).
3.3. Icariin inhibited inﬂammation response after cisplatin treatment
To verify whether cisplatin-induced nephrotoxicity was associated
with the onset of inﬂammation, we measured the contents of in-
ﬂammatory cytokines and mediators by Western blot and ELISA assay
kits, such as iNOS, NF-κB, TNF-α and IL-1β. As shown in Fig. 5A-C,
cisplatin treatment group resulted in increased protein expressions of
iNOS, p-NF-κB, TNF-α and IL-1β in HEK-293 cells, while the adminis-
tration of icariin at the dose range dramatically reduced these protein
expression levels by cisplatin (p < 0.05 or p < 0.01).
In addition, we measured the levels of TNF- α and IL-1β in culture
medium using ELISA kits. As shown in Fig. 5D and E, there were sig-
niﬁcant increases in TNF- α and IL-1β levels in cisplatin administered
groups (p < 0.01). Pretreatment with icariin obviously decreased the
levels of TNF-α and IL-1β in the cells (p < 0.05 or p < 0.01).
3.4. Icariin inhibited HEK-293 cell apoptosis after cisplatin treatment
To investigate whether icariin decreased cell apoptosis induced by
cisplatin, Hoechst 33258 staining was used to evaluate apoptosis degree
of HEK-293 cells in this report. As described in Fig. 6A and B, obvious
nuclear fragmentation and condensation of cells were observed in the
cisplatin group. However, the cells in icariin pretreatment groups ex-
hibited the regular homogeneous ﬂuorescent intensity and normal
Fig. 3. Eﬀects of diﬀerent concentration of Icariin or cisplatin on HEK-293 cells viability. The cell viability was assessed by MTT assay. (A) HEK-293 cells were
treated with cisplatin (0–80 μM). (B) HEK-293 cells treated with Icariin (0–2.0 μM). (C) HEK-293 cells treated with Icariin and cisplatin (0, 0.25, 0.5, 1.0, 2.0 μM).
Data are means ± SD (n= 6). *p < 0.05, **p < 0.01 vs. the control group ***p < 0.001 vs. the control group; #p < 0.05, ##p<0.01 vs. the cisplatin-treated
group.
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Fig. 4. Eﬀects of diﬀerent concentrations of Icariin against cisplatin-induced oxidative stress. Eﬀects of icariin on the levels of (A) MDA and (B) GSH in HEK-293
cells. Eﬀects of icariin with diﬀerent concentrations on ROS generation in cisplatin-induced HEK-293 cells (C). Data are means ± SD (n=6). *p < 0.05, **p <
0.01 vs. control group; #p < 0.05 or ##p<0.01 vs. cisplatin-treated group.
Fig. 5. Eﬀects of Icariin against cisplatin-induced cytotoxicity by regulating inﬂammation response. The protein expressions of IL-1β, TNF-α, iNOS, NF-κB(p65) and
p-NF-κB(p65) were measured by Western blotting with speciﬁc primary antibodies, and GAPDH protein level was used as a loading control (A). Quantiﬁcation of
relative protein expression was performed by densitometric analysis (B and C). Icariin decreased TNF-α (D) and IL-1β (E) levels in Cisplatin-induced cytotoxicity of
HEK-293 cells. All data are expressed as mean ± SD (n=3 in each group). * p<0.05, ** p<0.01 vs. control group; # p<0.05, ## p<0.01 vs. cisplatin-treated
group.
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contours (p<0.05 or p < 0.01).
To further measure the extent of apoptosis, we evaluated the ex-
pression levels of cleaved caspase-9/3, pro-apoptotic factor Bax and
anti-apoptotic factor Bcl-2 in all experimental groups by Western
blotting analysis. As shown in Fig. 6C-E, cisplatin signiﬁcantly in-
creased the protein expression levels of Bax and cleaved caspase-9/3,
while decreased the protein expression level of Bcl-2 (p<0.05 or
p<0.01). However, diﬀerent concentrations of icariin signiﬁcantly
increased expression level of Bcl-2 and decreased the expression levels
of cleaved-caspase 9/3 and Bax in HEK-293 cells (p<0.05 or
p<0.01).
3.5. Icariin activated the PI3K/Akt pathway that is inhibited by cisplatin
To verify the speciﬁc mechanism of cisplatin-induced apoptosis,
LY294002, an inhibitor of the PI3K/Akt, was employed to treat the cells
together with icariin. Treatment of cells with LY294002 (5 μM) prior to
the addition of cisplatin and icariin, the cell viability was measured by
MTT assay.
As shown in Fig. 7A, LY294002 signiﬁcantly exacerbates the via-
bility loss of cells exposed to cisplatin (p < 0.05). As previously,
icariin alleviated cisplatin-induced cytotoxicity; whereas addition of
LY294002 signiﬁcantly inhitited the protective eﬀect of icariin (Fig. 7B
and C) (p < 0.05 or p < 0.01). In addition, icariin pretreatment at a
dose of 1.0 μM signiﬁcantly increased Bcl-2 protein expresion, and
signiﬁcantly reduced Bax and cleaved caspase-3 protein expression as
compared to that in the cisplatin group. And, the regulating eﬀect of
icariin was signiﬁcantly inhibited by LY294002 (Fig. 7B and D) (p <
0.05 or p < 0.01). Overall, PI3K inhibitor LY294002 reversed the
protective eﬀects of icariin on cisplatin-stimulated HEK-293 cells. The
results suggested that the antiapoptotic action of icariin might be
mediated through PI3K/Akt signaling pathway.
4. Discussion
Cisplatin is one of the most eﬀective and common used anti-
neoplastic drug that is widely employed to treat patients with solid-
organ cancers [22]. Nephrotoxicity is the major limitation in cisplatin
based chemotherapy. Cisplatin treatment causes signiﬁcant ne-
phrotoxicity among other serious dose-limiting adverse eﬀects [23].
The pathogenesis of cisplatin-induced nephrotoxicity involves the
crosstalk of complex signal pathways leading to increased oxidative
stress and inﬂammation in kidney during the treatment, as well as
apoptosis of kidney tubular cells [5]. Thus far, there are very few ef-
fective approaches available to control cisplatin-induced ne-
phrotoxicity.
In this study, we assessed the protective eﬀects of icariin on cis-
platin-induced nephrotoxicity using HEK-293 cell model. Results
showed that icariin administration reduced cisplatin-induced oxidative
stress, apoptosis and inﬂammation, which were implicated in the pa-
thogenesis of renal dysfunction by cisplatin. The underlying molecular
mechanism involved a reduction of apoptosis regulated by PI3K/Akt-
mediated eﬀector caspase-9/3 and Bcl-2 family proteins, a suppression
of inﬂammatory factors including IL-1β, TNF-α, iNOS and an in-
activation of NF-κB.
Oxidative stress has been known as an important factor to promote
Fig. 6. Eﬀects of Icariin against cisplatin-induced cytotoxicity by regulating apoptotic. HEK-293 cells were stained with Hoechst 33258 (200×) (A). In the Hoechst
33258 staining, white arrows indicate apoptotic cells. Percentage of Hoechst 33258 -positive (B). The protein expressions of Bax, Bcl-2, Cleaved-caspase-9/3 and
Caspase-9/3, were measured by Western blotting with speciﬁc primary antibodies, and GAPDH protein level was used as a loading control (C). Quantiﬁcation of
relative protein expression was performed by densitometric analysis (D and E). All data were expressed as mean ± S.D., n = 3. * p<0.05, ** p<0.01 vs. control
group; # p<0.05, ## p<0.01 vs. cisplatin-treated group.
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cisplatin-induced nephrotoxicity through increasing the accumulation
of intracellular ROS [24–26]. Under normal physiological conditions,
cells control ROS level through balancing the generation of ROS and
their elimination by scavenging system [27]. Previous reports have
displayed that cisplatin damages anti-oxidant defense mechanisms fol-
lowed an apparent reduction in the level of GSH and elevation in MDA
content [28]. In our report, supplementation with icariin evidently re-
pressed the elevation of MDA and GSH contents in cisplatin-treated
HEK-293 cells, respectively. In addition, icariin pretreatment sig-
niﬁcantly attenuated the increase in ROS levels by 15.37%. Collec-
tively, icariin exerted signiﬁcant anti-oxidative eﬀect.
There is growing evidence showing that ROS-mediated apoptosis is
one of the important pathological mechanisms of cisplatin-induced
nephrotoxicity [5,7]. Excessive ROS accumulation would damage cel-
lular macromolecules such as proteins through activation of a series of
signaling cascades, including mitochondrial, apoptotic and PI3K/Akt
pathways [27]. When cisplatin accumulates in the mitochondrial ma-
trix, it causes a large amount of ROS production and mitochondrial
dysfunction, leading to increased mitochondrial permeability, pro‑a-
poptotic factor release and initiate apoptosis [29]. The Bcl-2 family of
proteins has a crucial role in the apoptotic mechanism of mitochondrial
pathway [30], which includes pro-apoptotic protein Bax and anti-
apoptotic protein Bcl-2 [31]. Bax is capable of activating caspase-9,
which is responsible for proteolytic activation of caspase 3 involved in
the cleavage of a group of proteins. In contrast, Bcl-2 exerts its anti-
apoptotic activity by inhibiting the translocation of Bax to mitochon-
dria [32–34]. In this study, icariin markedly decreased the cellular
apoptosis conﬁrmed by Hoechst 33258 staining in comparison with
cisplatin control group. We observed increases in Bax and cleaved
caspase 9/3 and decrease in Bcl-2 expression levels in cisplatin group.
Importantly, icariin eﬀectively reversed above alterations on Bax, cas-
pase 9/3 and Bcl-2, suggesting the protective eﬀect of icariin on cis-
platin-induced apoptosis.
In addition, ROS has been shown to play an important role in renal
tubulointerstitial inﬂammation and activation of NF-κB [35]. Many
studies have shown that the pathological process of cisplatin-induced
renal cell apoptosis is related to the release of many inﬂammatory
mediators such as TNF-α and IL-1β [36,37]. A study by Deng et al. has
demonstrated that icariin has a signiﬁcant anti-inﬂammatory eﬀect
[20]. Therefore, we hypothesized that icariin might exert anti-in-
ﬂammatory eﬀects on cisplatin-induced nephrotoxicity. As expected,
the results showed that compared with the control group, pretreatment
with icariin signiﬁcantly decreased the expression levels of phos-
phorylated NF-κB and iNOS, TNF-α, and IL-1β proteins. In conclusion,
these results suggest that icariin may act as an anti-inﬂammatory drug
for cisplatin-induced nephrotoxicity.
To further analyze the speciﬁc protective mechanisms of icariin in
cisplatin-induced cytotoxicity, we analyzed the expressions of PI3K/Akt
signaling pathway-related proteins in this experiment. The PI3K/Akt
pathway plays a vital role in proliferation, aging, survival, and apop-
tosis [38]. Nevertheless, excessive activation of PI3K/Akt pathway may
lead to neoplastic lesion [39]. Icariin stimulates the PI3K/Akt pathway
to exert antiapoptotic action [40,41], antioxidative stress [42] and
promotion of cell diﬀerentiation [43]. The protective eﬀect of icariin
against LPS-induced acute inﬂammatory responses is achived through
PI3K/Akt signaling pathway [44]. A study has shown that 25-Hydroxyl-
protopanaxatriol protected cardiomyocytes against H2O2-induced
apoptosis, in which molecular mechanism of action was summarized as
inhibition of pro-apoptotic protein Bax and activation of anti-apoptotic
protein Bcl-2 via PI3K/Akt pathway [45]. Treatment with LY294002, a
Fig. 7. LY294002 blocks the protective eﬀect of Icariin against cisplatin-induced injury to HEK-293 cells. HEK-293 cells were treated with cisplatin, Icariin and
LY294002. The HEK-293 cells were pretreated with LY294002 for 1 h and then incubated with 20 μM cisplatin for 24 h. Cell viability was assessed by MTT assay (A).
The protein expressions of PI3K, p-PI3K, Akt, p-Akt, Bax, Bcl-2, Cleaved-caspase-3, Caspase-3, were measured by Western blotting with speciﬁc primary antibodies,
and GAPDH protein level was used as a loading control (B). Quantiﬁcation of relative protein expression was performed by densitometric analysis (C and D). All data
were expressed as mean ± S.D., n=3. * p<0.05, ** p<0.01 vs. control group; # p<0.05, ## p<0.01 vs. cisplatin-treated group, & p<0.05, && p<0.00 vs.
cisplatin and icariin treated group.
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speciﬁc PI3K/Akt pathway inhibitor, abolished the protective eﬀect of
25-Hydroxyl-protopanaxatriol [45]. Similarly, in our study, the PI3K/
Akt pathway was inhibited after cisplatin exposure, and the combina-
tion of LY294002 and cisplatin enhanced this inhibition. Icariin treat-
ment attenuated cisplatin-induced inhibition of PI3K/Akt pathway.
PI3K inhibitor LY294002 may reduce the protective eﬀect of icariin.
In summary, we conclude that icariin has anti-oxidative stress, anti-
inﬂammatory and anti-apoptosis eﬀects. Main mechanism of action is
mediated by ROS-mediated PI3K/Akt pathway (Fig. 8).
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